Page | |
F - 2 | |
F - 3 | |
F - 4 | |
F - 5 | |
F - 6 | |
F - 7 – F - 24 |
June 30,
|
December 31,
|
|||||||
2025
|
2024
|
|||||||
(Unaudited)
|
(audited)
|
|||||||
ASSETS
|
||||||||
CURRENT ASSETS:
|
||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
||||
Marketable securities
|
|
|
||||||
Accounts receivable - net of allowance for credit losses of $
|
|
|
||||||
Prepaid expenses and other current assets
|
|
|
||||||
Total current assets
|
|
|
||||||
|
||||||||
Property and equipment, net
|
|
|
||||||
Operating lease right-of-use assets
|
|
|
||||||
Other long-term assets
|
|
|
||||||
Total long-term assets
|
|
|
||||||
Total assets
|
$
|
|
$
|
|
||||
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||
CURRENT LIABILITIES:
|
||||||||
Accounts payable
|
$
|
|
$
|
|
||||
Accrued expenses and other current liabilities
|
|
|
||||||
Deferred revenue, current
|
|
|
||||||
Operating lease liabilities, current
|
|
|
||||||
Total current liabilities
|
|
|
||||||
Operating lease liabilities, non-current
|
|
|
||||||
Deferred revenue, non-current
|
|
|
||||||
Total long-term liabilities
|
|
|
||||||
Total liabilities
|
|
|
||||||
COMMITMENTS AND CONTINGENCIES (NOTE 9)
|
||||||||
SHAREHOLDERS' EQUITY:
|
||||||||
Ordinary shares,
|
|
|
||||||
Founders’ shares
|
||||||||
Additional paid-in capital
|
|
|
||||||
Accumulated other comprehensive income
|
|
|
||||||
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||
Total shareholders’ equity
|
|
|
||||||
Total liabilities and shareholders’ equity
|
$
|
|
$
|
|
Six months ended June 30,
|
||||||||
2025
|
2024
|
|||||||
(Unaudited)
|
||||||||
Revenue
|
$
|
|
$
|
|
||||
Cost of revenue
|
|
|
||||||
Gross profit
|
|
|
||||||
OPERATING EXPENSES
|
||||||||
Research and development
|
|
|
||||||
Sales and marketing
|
|
|
||||||
General and administrative
|
|
|
||||||
Total operating expenses
|
|
|
||||||
Operating loss
|
(
|
)
|
(
|
)
|
||||
Financial income, net
|
|
|
||||||
Income before income taxes
|
|
|
||||||
Income tax expense
|
(
|
)
|
(
|
)
|
||||
Net income
|
$
|
|
$
|
|
||||
Net income per share attributable to ordinary shareholders, basic
|
$
|
|
$
|
|
||||
Net income per share attributable to ordinary shareholders, diluted
|
$
|
|
$
|
|
||||
Weighted-average ordinary shares used in calculating net income per ordinary share, basic
|
|
|
||||||
Weighted-average ordinary shares used in calculating net income per ordinary share, diluted
|
|
|
Six months ended June 30,
|
||||||||
2025
|
2024
|
|||||||
(Unaudited)
|
||||||||
Net Income
|
$
|
|
$
|
|
||||
Other comprehensive income (loss):
|
||||||||
Change in unrealized gains on marketable securities
|
||||||||
Unrealized losses arising during the period, net of tax
|
(
|
)
|
|
|||||
Losses (gains) reclassified into earnings, net of tax
|
|
|
||||||
Change in unrealized gains (losses) on cash flow hedges
|
||||||||
Unrealized gains (losses) arising during the period, net of tax
|
|
(
|
)
|
|||||
gains reclassified into earnings, net of tax
|
(
|
)
|
(
|
)
|
||||
Net current-period other comprehensive income (loss)
|
|
(
|
)
|
|||||
Comprehensive income
|
$
|
|
$
|
|
Number of Founders’
Shares
|
Number of Ordinary
shares
|
Additional Paid-in-
Capital
|
Accumulated Other
Comprehensive Income
(*)
|
Accumulated Deficit
|
Shareholders’ equity
|
|||||||||||||||||||
Balance as of January 1, 2025
|
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||||||
Exercise of options
|
|
|
|
|
|
|
||||||||||||||||||
Issuance of ordinary shares upon vesting of restricted share units
|
|
|
|
|
|
|
||||||||||||||||||
Issuance of ordinary shares under employee share purchase plan
|
|
|
|
|
|
|
||||||||||||||||||
Share-based compensation
|
-
|
-
|
|
|
|
|
||||||||||||||||||
Other comprehensive income
|
-
|
-
|
|
|
|
|
||||||||||||||||||
Net income
|
-
|
-
|
|
|
|
|
||||||||||||||||||
Balance as of June 30, 2025 (unaudited)
|
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||||||
Balance as of January 1, 2024
|
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||||||
Exercise of options
|
|
|
|
|
|
|
||||||||||||||||||
Issuance of ordinary shares upon vesting of restricted share units
|
|
|
|
|
|
|
||||||||||||||||||
Issuance of ordinary shares under employee share purchase plan
|
|
|
|
|
|
|
||||||||||||||||||
Share-based compensation
|
-
|
-
|
|
|
|
|
||||||||||||||||||
Other comprehensive loss
|
-
|
-
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
Net income
|
-
|
-
|
|
|
|
|
||||||||||||||||||
Balance as of June 30, 2024 (unaudited)
|
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
Six months ended June 30,
|
||||||||
2025
|
2024
|
|||||||
(Unaudited)
|
||||||||
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
Net income
|
$
|
|
$
|
|
||||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
Depreciation and amortization
|
|
|
||||||
Share-based compensation
|
|
|
||||||
Amortization of discount and accretion of interest on marketable securities
|
(
|
)
|
|
|||||
Changes in operating assets and liabilities:
|
||||||||
Accounts receivable, net
|
(
|
)
|
(
|
)
|
||||
Prepaid expenses and other assets
|
(
|
)
|
(
|
)
|
||||
Accounts payable
|
|
|
||||||
Accrued expenses and other liabilities
|
|
|
||||||
Deferred revenue
|
|
|
||||||
Net cash provided by operating activities
|
|
|
||||||
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
Purchase of property and equipment
|
(
|
)
|
(
|
)
|
||||
Capitalized software development costs
|
(
|
)
|
(
|
)
|
||||
Purchase of marketable securities
|
(
|
)
|
|
|||||
Net cash used in investing activities
|
(
|
)
|
(
|
)
|
||||
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
Proceeds from exercise of share options and employee share purchase plan
|
|
|
||||||
Receipt (repayment)of tax advance relating to exercises of share options and RSUs, net
|
(
|
)
|
|
|||||
Net cash provided by financing activities
|
|
|
||||||
|
||||||||
INCREASE IN CASH, AND CASH EQUIVALENTS
|
|
|
||||||
CASH AND CASH EQUIVALENTS - Beginning of period
|
|
|
||||||
CASH AND CASH EQUIVALENTS - End of period
|
$
|
|
$
|
|
||||
NON-CASH INVESTING AND FINANCING ACTIVITIES:
|
||||||||
Non-cash purchases of property and equipment
|
$
|
|
$
|
|
||||
Capitalized share-based compensation costs
|
$
|
|
$
|
|
||||
Right-of-use asset recognized with corresponding lease liability
|
$
|
|
$
|
|
NOTE 1:-
|
ORGANIZATION AND DESCRIPTION OF BUSINESS
|
NOTE 2:-
|
BASIS OF PRESENTATION and SIGNIFICANT ACCOUNTING POLICIES
|
|
a.
|
Unaudited Interim Condensed Consolidated Financial Information
|
F - 7
![]() |
MONDAY.COM AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2:-
|
BASIS OF PRESENTATION and SIGNIFICANT ACCOUNTING POLICIES (cont.)
|
F - 8
![]() |
MONDAY.COM AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2:-
|
BASIS OF PRESENTATION and SIGNIFICANT ACCOUNTING POLICIES (cont.)
|
b.
|
Use of estimates
|
c.
|
Accounting pronouncements not yet effective
|
F - 9
![]() |
MONDAY.COM AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 3:-
|
REVENUE RECOGNITION
|
Six months ended June 30,
|
||||||||
2025
|
2024
|
|||||||
(Unaudited)
|
||||||||
Beginning balance
|
$
|
|
$
|
|
||||
Capitalization of deferred contract costs
|
|
|
||||||
Amortization
|
(
|
)
|
(
|
)
|
||||
Ending balance
|
$
|
|
$
|
|
June 30,
2025
|
December 31,
2024
|
|||||||
(Unaudited)
|
||||||||
Deferred contract costs, current
|
$
|
|
$
|
|
||||
Deferred contract costs, noncurrent
|
|
|
||||||
Total deferred contract costs
|
$
|
|
$
|
|
F - 10
![]() |
MONDAY.COM AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 3:-
|
REVENUE RECOGNITION (cont.)
|
NOTE 4:-
|
CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES
|
June 30,
|
December 31,
|
|||||||
2025
|
2024
|
|||||||
(Unaudited)
|
||||||||
Cash and cash equivalents:
|
||||||||
Cash
|
$
|
|
$
|
|
||||
Bank deposits
|
|
|
||||||
Money market funds
|
|
|
||||||
Total cash and cash equivalents
|
|
|
||||||
Marketable securities:
|
||||||||
U.S. Treasury bills
|
|
|
||||||
Total marketable securities
|
|
|
||||||
Total cash and cash equivalents and marketable securities
|
$
|
|
$
|
|
June 30, 2025
|
||||||||||||||||
(Unaudited)
|
||||||||||||||||
Amortized cost
|
Gross unrealized gains
|
Gross unrealized losses
|
Fair value
|
|||||||||||||
Contractual maturity:
|
||||||||||||||||
Within one year
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
After one year through five years
|
|
|
|
|
||||||||||||
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
F - 11
![]() |
MONDAY.COM AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 4:-
|
CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES (cont.)
|
December 31, 2024
|
||||||||||||||||
Amortized cost
|
Gross unrealized gains
|
Gross unrealized losses
|
Fair value
|
|||||||||||||
Contractual maturity:
|
||||||||||||||||
Within one year
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
After one year through five years
|
|
|
|
|
||||||||||||
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
NOTE 5:-
|
PREPAID EXPENSES AND OTHER CURRENT ASSETS
|
June 30,
|
December 31,
|
|||||||
2025
|
2024
|
|||||||
(Unaudited)
|
||||||||
Prepaid expenses
|
$
|
|
$
|
|
||||
Related parties’ receivable
|
|
|
||||||
Government institutions
|
|
|
||||||
Derivative instruments
|
|
|
||||||
Interest receivable
|
|
|
||||||
Short-term vendor deposits
|
|
|
||||||
Deferred contract costs
|
|
|
||||||
Other current assets
|
|
|
||||||
Total prepaid expenses and other current assets
|
$
|
|
$
|
|
NOTE 6:-
|
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
|
June 30,
|
December 31,
|
|||||||
2025
|
2024
|
|||||||
(Unaudited)
|
||||||||
Accrued employee compensation and benefits
|
$
|
|
$
|
|
||||
Accrued expenses
|
|
|
||||||
Advances from customers
|
|
|
||||||
Income and indirect taxes payable
|
|
|
||||||
Total
|
$
|
|
$
|
|
F - 12
![]() |
MONDAY.COM AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 7:-
|
FAIR VALUE MEASUREMENTS
|
As of June 30,
|
As of December 31,
|
|||||||||||||||||||||||
2025
|
2024
|
|||||||||||||||||||||||
Level 1
|
Level 2
|
Total
|
Level 1
|
Level 2
|
Total
|
|||||||||||||||||||
(Unaudited)
|
||||||||||||||||||||||||
Cash equivalents:
|
||||||||||||||||||||||||
Money market funds
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
Marketable securities:
|
||||||||||||||||||||||||
U.S. Treasury bills
|
|
|
|
|
|
|
||||||||||||||||||
Foreign currency derivative contracts:
|
||||||||||||||||||||||||
Foreign exchange contracts
|
|
|
|
|
|
|
||||||||||||||||||
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
NOTE 8:-
|
DERIVATIVES AND HEDGING
|
F - 13
![]() |
MONDAY.COM AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 8:-
|
DERIVATIVES AND HEDGING (cont.)
|
June 30,
|
December 31,
|
||||||||
Balance sheet line item
|
2025
|
2024
|
|||||||
(Unaudited)
|
|||||||||
Derivatives designated as hedging instruments:
|
|||||||||
Foreign exchange contracts
|
|
$
|
|
$
|
|
||||
|
|
||||||||
Derivatives not designated as hedging instruments:
|
|||||||||
|
|
||||||||
Total
|
$
|
|
$
|
|
Gain (Loss) Recognized
in Other Comprehensive
Income on Effective-
Portion of Derivative, net
|
Realized gains on Derivative Reclassified from Accumulated Other Comprehensive Income (*)
|
Amount Excluded from Effectiveness Testing Recognized in Income (Loss)
|
||||||||||||||||||||||
Six months ended June 30
|
Six months ended June 30
|
Six months ended June 30
|
||||||||||||||||||||||
2025
|
2024
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||||||||
(Unaudited)
|
||||||||||||||||||||||||
Derivatives designated as hedging instruments:
|
||||||||||||||||||||||||
Foreign exchange contracts
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||
|
(
|
)
|
|
|
(
|
)
|
|
|||||||||||||||||
Derivatives not designated as hedging instruments:
|
||||||||||||||||||||||||
Foreign exchange contracts
|
|
|
|
|
|
|
||||||||||||||||||
Total
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
F - 14
![]() |
MONDAY.COM AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 8:-
|
DERIVATIVES AND HEDGING (cont.)
|
June 30,
2025
|
December 31,
2024
|
|||||||
(Unaudited)
|
||||||||
Derivatives designated as hedging instruments:
|
||||||||
Foreign exchange contracts:
|
||||||||
NIS
|
$
|
|
$
|
|
||||
Total
|
$
|
|
$
|
|
NOTE 9:-
|
LEASES
|
Amount (*)
|
||||
The remainder of 2025
|
$
|
|
||
2026
|
|
|||
2027
|
|
|||
2028
|
|
|||
2029
|
|
|||
Thereafter
|
|
|||
Total undiscounted cash flows
|
$
|
|
||
Less: Imputed interest
|
$
|
(
|
)
|
|
Present value of lease liabilities
|
$
|
|
F - 15
![]() |
MONDAY.COM AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 9:-
|
LEASES (cont.)
|
June 30,
2025
|
December 31,
2024
|
|||||||
(Unaudited)
|
||||||||
Weighted-average remaining lease term
|
|
|
||||||
Weighted-average discount rate
|
|
%
|
|
%
|
NOTE 10:-
|
COMMITMENTS AND CONTINGENCIES
|
a.
|
Guarantees
|
b.
|
Indemnifications
|
F - 16
![]() |
MONDAY.COM AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 10:-
|
COMMITMENTS AND CONTINGENCIES (cont.)
|
c.
|
Legal Contingencies
|
d.
|
Other Commitments
|
Amount
|
||||
The remainder of 2025
|
$
|
|
||
2026
|
|
|||
2027
|
|
|||
2028
|
|
|||
Total contractual obligations
|
$
|
|
F - 17
![]() |
MONDAY.COM AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 11:-
|
FINANCIAL INCOME, NET
|
Six months ended June 30,
|
||||||||
2025
|
2024
|
|||||||
(Unaudited)
|
||||||||
Financial expenses:
|
||||||||
Bank charges and other
|
$
|
|
$
|
|
||||
Exchange rate expense, net
|
|
|
||||||
Total financial expenses
|
|
|
||||||
Financial income:
|
||||||||
Exchange rate income, net
|
|
|
||||||
Interest income on deposits, money market funds and marketable securities
|
|
|
||||||
Accretion of discount on marketable securities
|
|
|
||||||
Total financial income
|
|
|
||||||
Financial income, net
|
$
|
|
$
|
|
NOTE 12:-
|
RELATED PARTIES
|
NOTE 13:-
|
SHAREHOLDERS’ EQUITY
|
a.
|
Ordinary shares
|
June 30,
2025
|
December 31,
2024
|
|||||||
(Unaudited)
|
||||||||
Ordinary shares
|
|
|
||||||
Outstanding share options and RSUs
|
|
|
||||||
Shares available for future grants under the 2021 plan
|
|
|
||||||
Shares available for future grants under the 2024 Foundation plan
|
|
|
||||||
Shares subject to the employee share purchase plan
|
|
|
||||||
Total
|
|
|
F - 18
![]() |
MONDAY.COM AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 13:-
|
SHAREHOLDERS’ EQUITY (cont.)
|
b.
|
Share-based compensation
|
Number of Options
|
Weighted-Average Exercise Price
|
Weighted Average Remaining Contractual life
|
Aggregate Intrinsic Value
|
|||||||||||||
(Unaudited)
|
||||||||||||||||
Outstanding — January 1, 2025 (*)
|
|
$
|
|
|
$
|
|
||||||||||
Granted (*)
|
|
$
|
|
|||||||||||||
Exercised
|
(
|
)
|
$
|
|
||||||||||||
Expired and forfeited
|
(
|
)
|
$
|
|
||||||||||||
Outstanding — June 30, 2025
|
|
$
|
|
|
$
|
|
||||||||||
Exercisable — June 30, 2025 (*)
|
|
$
|
|
|
$
|
|
F - 19
![]() |
MONDAY.COM AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 13:-
|
SHAREHOLDERS’ EQUITY (cont.)
|
Number of Units
|
Weighted-Average Fair Value
|
|||||||
(Unaudited)
|
||||||||
Balance at January 1, 2025 (*)
|
|
$
|
|
|||||
Granted (*)
|
|
$
|
|
|||||
Vested
|
(
|
)
|
$
|
|
||||
Canceled
|
(
|
)
|
$
|
|
||||
Balance at June 30, 2025 (*)
|
|
$
|
|
Six months ended June 30,
|
||||||||
2025
|
2024
|
|||||||
Cost of revenues
|
$
|
|
$
|
|
||||
Research and development
|
|
|
||||||
Sales and marketing
|
|
|
||||||
General and administrative
|
|
|
||||||
Share-based compensation, net of amounts capitalized
|
$
|
|
$
|
|
||||
Capitalized share-based compensation expense
|
|
|
||||||
Total share-based compensation
|
$
|
|
$
|
|
F - 20
![]() |
MONDAY.COM AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 13:-
|
SHAREHOLDERS’ EQUITY (cont.)
|
Six months ended June 30,
|
||||||||
2025
|
2024
|
|||||||
(Unaudited)
|
||||||||
Risk-free interest rate
|
|
|
|
|
||||
Expected dividend yield
|
|
|
|
|
||||
Expected term (in years)
|
|
|
||||||
Expected volatility
|
|
|
|
|
c.
|
Employee Share Purchase Plan
|
F - 21
![]() |
MONDAY.COM AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 14:-
|
EARNINGS PER SHARE
|
Six months ended June 30,
|
||||||||
2025
|
2024
|
|||||||
Numerator:
|
(Unaudited)
|
|||||||
Net income attributable to ordinary shareholders, basic and diluted
|
$
|
|
$
|
|
||||
Denominator:
|
||||||||
Weighted-average ordinary shares outstanding, basic
|
|
|
||||||
Dilutive effect
|
||||||||
Employee stock options, RSUs and PSUs
|
|
|
||||||
Weighted average ordinary shares outstanding, diluted
|
|
|
||||||
Net income per share attributable to ordinary shareholders, basic
|
$
|
|
$
|
|
||||
Net income per share attributable to ordinary shareholders, diluted
|
$
|
|
$
|
|
Six months ended June 30,
|
||||||||
2025
|
2024
|
|||||||
(Unaudited)
|
||||||||
Options
|
|
|
||||||
RSUs
|
|
|
||||||
Total
|
|
|
F - 22
![]() |
MONDAY.COM AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 15:-
|
SEGMENT REPORTING
|
Six months ended June 30,
|
||||||||
2025
|
2024
|
|||||||
Total revenues
|
$
|
|
|
|||||
Share-based compensation
|
(
|
)
|
(
|
)
|
||||
Tax benefit (expense) related to share-based compensation
|
(
|
)
|
|
|||||
Other segment items (*)
|
(
|
)
|
(
|
)
|
||||
Net income
|
$
|
|
$
|
|
Six months ended June 30,
|
||||||||
2025
|
2024
|
|||||||
(Unaudited)
|
||||||||
United States
|
$
|
|
$
|
|
||||
EMEA
|
|
|
||||||
United Kingdom
|
|
|
||||||
Rest of the world
|
|
|
||||||
Total
|
$
|
|
$
|
|
F - 23
![]() |
MONDAY.COM AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 15:-
|
SEGMENT REPORTING (cont.)
|
As of
June 30,
2025
|
As of
December 31,
2024
|
|||||||
(Unaudited)
|
||||||||
Israel
|
$
|
|
$
|
|
||||
United States
|
|
|
||||||
United Kingdom
|
|
|
||||||
Rest of the world
|
|
|
||||||
Total
|
$
|
|
$
|
|